AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shadid, R.
Right arrow Articles by Krauss-Etschmann, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shadid, R.
Right arrow Articles by Krauss-Etschmann, S.
Agricola
Right arrow Articles by Shadid, R.
Right arrow Articles by Krauss-Etschmann, S.
American Journal of Clinical Nutrition, Vol. 86, No. 5, 1426-1437, November 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study1,2,3

Rania Shadid, Monique Haarman, Jan Knol, Winfried Theis, Christopher Beermann, Dorothea Rjosk-Dendorfer, Dolores J Schendel, Berthold V Koletzko and Susanne Krauss-Etschmann

1 From the Pediatric Immune Regulation Clinical Cooperation Group, Ludwig-Maximilians University of Munich (RS and SK-E); the GSF-National Research Center for Environment and Health, Neuherberg, Germany (RS and SK-E); the Department of Biomedical Research, Numico Research, Wageningen, Netherlands (MH and JK); the Department of Statistics, Faculty of Mathematics and Natural Science, University of Dortmund, Dortmund, Germany (WT); Numico Research Germany, Friedrichsdorf, Germany (CB); the First Department of Obstetrics and Gynecology, Ludwig-Maximilians University, Munich, Germany (DRD); the Institute of Molecular Immunology and the Immune Monitoring Clinical Cooperation Group, GSF-National Research Center for Environment and Health, Munich, Germany (DJS); and the Division of Metabolic Diseases and Nutritional Medicine, Children's Hospital of the Ludwig-Maximilians University of Munich, Munich, Germany (BVK)

Background: Galactooligosaccharides (GOS) and long-chain fructooligosaccharides (lcFOS) proliferate bifidobacteria in infant gut microbiota. However, it is not known how GOS and FOS influence the microbiota of pregnant women and whether a potential prebiotic effect is transferred to the offspring.

Objectives: We aimed to test how supplementation with GOS and lcFOS (GOS/lcFOS) in the last trimester of pregnancy affects maternal and neonatal gut microbiota. Variables of fetal immunity were assessed as a secondary outcome.

Design: In a randomized, double-blind, placebo-controlled pilot study, 48 pregnant women were supplemented 3 times/d with 3 g GOS/lcFOS (at a ratio of 9:1) or maltodextrin (placebo) from week 25 of gestation until delivery. Percentages of bifidobacteria and lactobacilli within total bacterial counts were detected by fluorescent in situ hybridization and quantitative polymerase chain reaction in maternal and neonatal (days 5, 20, and {approx}182) stool samples. Variables of fetal immunity were assessed in cord blood by using flow cytometry and cytokine multiplex-array analysis.

Results: The proportions of bifidobacteria in the maternal gut were significantly higher in the supplemented group than in the placebo group (21.0% and 12.4%, respectively; P = 0.026); the proportion of lactobacilli did not differ between the groups. In neonates, bifidobacteria and lactobacilli percentages, diversity and similarity indexes, and fetal immune parameters did not differ significantly between the 2 groups. Mother-neonate similarity indexes of bifidobacteria decreased over time.

Conclusions: GOS/lcFOS supplementation has a bifidogenic effect on maternal gut microbiota that is not transferred to neonates. The increased maternal bifidobacteria did not affect fetal immunity as measured by a comprehensive examination of cord blood immunity variables.

Key Words: Galactooligosaccharides • fructooligosaccharides • prebiotics • pregnancy • microbiota • fetal immunity




This article has been cited by other articles:


Home page
J. Nutr.Home page
G. Boehm and G. Moro
Structural and Functional Aspects of Prebiotics Used in Infant Nutrition
J. Nutr., September 1, 2008; 138(9): 1818S - 1828S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition